Cargando…
Silencing of Barkor/ATG14 sensitizes osteosarcoma cells to cisplatin-induced apoptosis
Although surgical excision following neoadjuvant chemotherapy has contributed to the long-term survival of osteosarcoma patients, patients that do not respond to commonly used drugs including cisplatin, have a poor prognosis. Autophagy is important in the inhibition of chemotherapeutic apoptosis. Th...
Autores principales: | ZHAO, ZHIFANG, TAO, LIJIANG, SHEN, CHENGCHUN, LIU, BING, YANG, ZHENGMING, TAO, HUIMIN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896476/ https://www.ncbi.nlm.nih.gov/pubmed/24337183 http://dx.doi.org/10.3892/ijmm.2013.1578 |
Ejemplares similares
-
Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin
por: Qu, Yang, et al.
Publicado: (2022) -
Checkpoint kinase inhibitor AZD7762 enhance cisplatin-induced apoptosis in osteosarcoma cells
por: Zhu, Jian, et al.
Publicado: (2019) -
Knockdown of Akt Sensitizes Osteosarcoma Cells to Apoptosis Induced by Cisplatin Treatment
por: Zhang, Guoyou, et al.
Publicado: (2011) -
Volume-sensitive chloride channels are involved in cisplatin treatment of osteosarcoma
por: CAI, SIYI, et al.
Publicado: (2015) -
Estrogen receptor β induces autophagy of osteosarcoma through the mTOR signaling pathway
por: Yang, Zhengming, et al.
Publicado: (2020)